Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer

BMJ Case Rep. 2018 Mar 15:2018:bcr2017223474. doi: 10.1136/bcr-2017-223474.

Abstract

Tumour lysis syndrome (TLS) is a rare oncological emergency in solid tumours. Because it is associated with bad short-term prognosis, early recognition and treatment are mandatory. This case refers to a middle-aged woman who presented with stage IV colon cancer, with massive hepatic involvement. After three cycles of first-line FOLFOX (folinic acid, 5-fluorouracil and oxaliplatin), she developed acute kidney injury and hyperkalaemia that did not respond to standard measures. High suspicion of TLS prompted further corroborating investigations and early intensive care unit admission. With vigorous hydration and allopurinol, TLS completely resolved and the patient was discharged. Prophylaxis of subsequent TLS recurrence was complicated by biopsy-proven neutrophilic vasculitis secondary to allopurinol. Prevention of TLS with hydration and rasburicase was performed prior to each subsequent cycle of chemotherapy. This case report is intended to highlight risk factors for TLS in solid tumours and focus on treatment and secondary prophylaxis of TLS.

Keywords: acute renal failure; chemotherapy; colon cancer; fluid electrolyte and acid-base disturbances.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Allopurinol / administration & dosage
  • Allopurinol / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Colonic Neoplasms / diagnosis*
  • Colonic Neoplasms / diagnostic imaging
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / pathology
  • Diagnosis, Differential
  • Female
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use
  • Humans
  • Leucovorin / adverse effects
  • Leucovorin / therapeutic use
  • Liver Neoplasms / diagnosis*
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Middle Aged
  • Organoplatinum Compounds / adverse effects
  • Organoplatinum Compounds / therapeutic use
  • Palliative Care
  • Tomography, X-Ray Computed
  • Tumor Lysis Syndrome / diagnosis*
  • Tumor Lysis Syndrome / drug therapy
  • Tumor Lysis Syndrome / etiology

Substances

  • Organoplatinum Compounds
  • Allopurinol
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol